Correction to: The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury

Laura Brandolini; Marta Grannonico; Gianluca Bianchini; Alessia Colanardi; Pierluigi Sebastiani; Antonella Paladini; Alba Piroli; Marcello Allegretti; Giustino Varrassi; Silvia Di Loreto

doi:10.1007/s12640-019-00049-3

Correction to: The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury

Neurotox Res. 2019 Aug;36(2):439. doi: 10.1007/s12640-019-00049-3.

Affiliations

¹ Dompé Farmaceutici SpA, Via Campo di Pile, L'Aquila, Italy.
² Department of MESVA, University of L'Aquila, L'Aquila, Italy.
³ Institute of Translational Pharmacology (IFT) - National Council of Research (CNR), L'Aquila, Italy.
⁴ Paolo Procacci Foundation, Via Tacito 7, 00193, Rome, Italy.
⁵ Institute of Translational Pharmacology (IFT) - National Council of Research (CNR), L'Aquila, Italy. silvia.diloreto@cnr.it.

Abstract

The article The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury, written by Laura Brandolini, Marta Grannonico, Gianluca Bianchini, Alessia Colanardi, Pierluigi Sebastiani, Antonella Paladini, Alba Piroli, Marcello Allegretti, and Giustino Varrassi.

Publication types

Published Erratum